Objective: Reconstruction as part of treatment for breast cancer is aimed at mitigating body image concerns after mastectomy. Although algorithms have been developed to objectively assess breast reconstruction outcomes, associations between objectively quantified breast aesthetic appearance and patient-reported body image outcomes have not been examined.
| BACKGROUND
Reconstruction as part of treatment for breast cancer is intended to restore the appearance of a woman's breast(s) to mitigate body image dissatisfaction and improve quality of life after mastectomy. [1] [2] [3] [4] [5] [6] Recent years have seen an upward trend in the rates of women opting for breast reconstruction as part of their cancer treatment, 7, 8 with one study 8 reporting an increase from 46% to 63% of women with employment-based insurance in the United States choosing to do so between 1997 and 2007. This underscores the important role of breast reconstruction in restoring a woman's overall body image. 9, 10 However, factors that influence the body image satisfaction of patients who seek reconstruction are not well understood. 11 It is assumed that a combination of factors influence body image outcomes, including the aesthetic outcomes of the reconstructive surgery, patients' own values, and clinical factors (eg, BMI, cancer treatment history, and surgical complications). 10 Previous studies have revealed a lack of assessment criteria and reliable evaluation methods to assess aesthetic outcomes of breast reconstruction. 12 Methods for evaluating reconstruction outcomes can be organized into 3 broad groups: patient-reported outcomes, subjective observer ratings, and objective measurements. Patientreported outcomes assess patient's perception of their reconstructed breasts and their satisfaction with the outcomes (eg, Breast Reconstruction Satisfaction Questionnaire and Breast Q). [13] [14] [15] Subjective observer ratings are typically conducted by surgeons and other health care professionals to evaluate their impressions of a patient's outcome.
Although subjective observer ratings are widely reported in the literature, they are known to have high interobserver discrepancies. 16, 17 A systematic review that examined assessment of cosmesis after breast reconstruction surgery reported that majority of the 122 studies examined relied on clinical and photographic ratings, while only 13 studies were found to use objective geometric assessments of the reconstructed breast(s). 18 Indeed, objective assessments of breast reconstruction are being increasingly developed to measure specific reconstruction outcomes such as breast symmetry (eg, Breast Retraction Index and Breast Symmetry Index). 16, 19, 20 Objective measures offer distinct advantages for obtaining valid and reliable data on relevant outcomes for women undergoing breast reconstruction treatment. However, objective assessments of breast reconstruction outcomes must be considered in conjunction with patient-reported outcomes. A patient's assessment of her body image following breast reconstruction is critical to evaluate considering the ultimate goal is to recreate the appearance of a breast (or breasts) that is satisfying to the patient.
Research suggests patient characteristics can strongly influence patient-reported outcomes among breast cancer patients, for instance, patient personality traits 21, 22 and patient values regarding their appearance (ie, appearance investment). 23, 24 Appearance investment, which refers to the degree to which an individual values his or her appearance and believes their self-worth is contingent upon appearance, may be particularly relevant to consider in this patient population who experience significant changes in the way their bodies look, feel, and function as a result of treatment. Although reconstructive surgery is aimed at restoring the appearance of the breast, either by repairing the defects associated with segmental mastectomy or reconstructing the breast mound after a total mastectomy, it is possible that appearance investment influences the surgical expectations of patients that in turn have bearing on perceived reconstructive outcomes.
The purpose of this study was to conduct a novel investigation of associations between objectively quantified breast aesthetic appearance and patient-reported body image outcomes for women undergoing breast reconstruction as part of cancer treatment. We examined the extent to which breast symmetry and appearance investment were associated with body image dissatisfaction while controlling for clinical factors (ie, BMI, cancer treatment history, surgical complications, and characteristics of the breast reconstruction). We chose symmetry as an objective parameter of interest as it is considered an important aesthetic outcome of breast reconstruction and can be easily measured by both patients and trained observers. 25, 26 We also sought to understand the role of appearance investment in predicting body image outcomes as that may be an important target of body image-focused interventions.
| METHODS
The study sample consisted of adult female breast cancer patients 
| Breast symmetry
Vertical extent (VE) and horizontal extent (HE) of the patients' breasts were calculated using 2-dimensional ( 
Horizontal extent represents the ratio of horizontal distances of 
where f1(x) = e −(x−1)
.
| Body image investment
The Appearance Schemas Inventory-Revised, 27 
| RESULTS
Of the 220 participants who were recruited for the parent study, 30
were excluded from the current study owing to missing clinical photographs or self-report questionnaires, leaving a final sample size of 190 participants. Table 1 presents the descriptive statistics of our sample.
Participants' mean age was 49 years (SD = 9 y). The majority of participants were Caucasian (89%) and married (70%). A proportion of the sample had undergone chemotherapy (44%) and radiation 
| Associations among clinical factors and breast symmetry
Greater BMI was significantly associated with VE and HE symmetry (r = −0.22, P < .01; r = 0.19, P < .05). Surgical complications were significantly associated with decreased VE symmetry (r = −0.17, P < .05) but not HE symmetry. Type of reconstruction (ie, autologous reconstruction) was associated with a significant decrease in HE symmetry (r = −0.15, P < .05) but not VE symmetry. Prior chemotherapy, prior radiation therapy, reconstruction timing, and stage of reconstruction were not significantly associated with symmetry.
| Associations among clinical factors, appearance investment, and body image dissatisfaction
The clinical factors assessed in this study were not significantly associated with appearance investment. Prior chemotherapy was significantly associated with higher body image dissatisfaction (r = 0.19, P < .01). Body mass index, prior radiation therapy, surgical complications, reconstruction timing, reconstruction type, and reconstruction stage were not significantly associated with body image dissatisfaction. Appearance investment was significantly associated with body image dissatisfaction (r = 0.38, P < .001).
| Associations between breast symmetry and body image dissatisfaction
We found VE symmetry to be significantly associated with body image dissatisfaction (r = −0.16, P < .05). Decreased VE symmetry was associated with higher body image dissatisfaction. Horizontal extent, which is the ratio of distances between the midline and lateral extent, was not significantly associated with body image dissatisfaction (r = −0.07, P = .37). As such, HE was not considered as a predictor of body image dissatisfaction in subsequent analyses.
| Breast symmetry and appearance investment and their associations with body image dissatisfaction controlling for clinical factors
In multi-variable regression analysis, body image dissatisfaction was significantly associated with both VE symmetry, β = −.19, t(179) = −2.50, P < .05, and appearance investment, β = .45, t(179) = 6.25, P < .001, controlling for BMI, prior chemotherapy, prior radiation therapy, history of surgical complications, and reconstruction characteristics (Table 3) Abbreviations: BIS, Body Image Scale; ASI-R, Appearance Schemas Inventory.
| CONCLUSIONS
In this study, we found that VE symmetry in conjunction with appearance investment significantly predicted body image dissatisfaction in our sample of breast cancer patients at various stages of reconstruction. Our findings suggest that there are diverse factors that influence body image outcomes for this patient population including objectively assessed aesthetic results of the reconstruction, patients' own values regarding appearance, and clinical-/treatment-related factors (in this case, being in the final stages of reconstruction and undergoing chemotherapy). These findings are consistent with theoretical models of body image, which point to the roles inherent individual characteristics, historical influences, cultural environment, and life experiences can have on body image development. 10, 31 Cancer and its treatment represent a proximal influence that can further shape a patient's body image, particularly when it results in visible changes to the body. In this study, greater breast asymmetry was a significant predictor of body image dissatisfaction; however, there were other factors that explained body image dissatisfaction as well.
| Clinical implications
Appearance investment was identified as an important predictor of body image dissatisfaction and relates to the degree to which an individual values one's appearance and tends to link one's self-worth with one's appearance. Higher appearance investment relates to greater body image dissatisfaction and represents an important potential target for psychotherapeutic intervention. Body image-focused therapy is effective in challenging appearance assumptions that contribute to body image dissatisfaction [32] [33] [34] and appears highly relevant and warranted for this patient population. Our results further indicated that the stage of reconstruction was significantly associated with body image. Not surprisingly, participants who were in the final stage of reconstruction reported lower levels of body image dissatisfaction compared with those preparing to undergo reconstruction. Although body image is expected to improve over time as patients undergo reconstruction, our findings also indicate that it is important to consider the potential lasting impact of chemotherapy upon a patient's body image. We found that having undergone chemotherapy prior to commencing reconstruction was marginally associated with increased body image dissatisfaction. These findings presumably relate to the physical and psychological effects from appearance changes due to chemotherapy, such as hair loss and weight change.
On the basis of our findings, VE symmetry appears to be more important than HE symmetry in capturing body image dissatisfaction.
While some research exists as to how humans perceive symmetry across an axis (eg, symmetry is more salient closer to the axis), there is limited research about how humans perceive different types of symmetry across the same axis. 35 Given that the scores in our sample for HE symmetry are overall more variable compared with those of VE symmetry, our results are indeed interesting; nevertheless, further research is needed in this area to provide a more compelling explanation for this phenomenon. This finding has potential important implications for further guiding reconstructive surgeons performing the procedures and whose undoubted goal is to achieve the best aesthetic outcome (including symmetry); if data continue to support that VE symmetry is more important to a patient's body image satisfaction than HE symmetry, greater emphasis should be expended toward achieving VE symmetry. It will be important for future studies to investigate breast symmetry in conjunction with other aspects of appearance-related outcomes of breast reconstruction such as scarring, rippling, dimpling, and distortion of shape from capsular contracture to determine if there are certain characteristics that are more salient than others.
Our findings further suggest that the clinical 2-D photographs with anterior-posterior perspective and fiducial points that we used were adequate in capturing breast aesthetic outcomes that are associated with body image. This study used 2 fiducial points to calculate symmetry of the reconstructed breast based on clinical 2-D images. However, there are a number of other fiducial points that can be considered for symmetry calculations, including the nipple. We were not able to use the nipple as a landmark because a significant proportion of our sample was without a nipple-areola complex as they were in the process of undergoing reconstruction. There are recent innovations in objective measures, for instance, the use of 3-dimensional imaging to quantify additional properties such as breast volume and texture. 17, 20, 36, 37 There are also a number of other aspects of reconstruction outcomes including assessment of shape, discoloration, and position of the nipple-areola that can be considered in future studies.
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| Study limitations
Our study had a number of limitations. The sample we used reflects the current usage of breast reconstruction in the United States and thus lacked racial and ethnic diversity, making the results difficult to generalize to non-Caucasian populations. The design of the study was cross-sectional, limiting the ability to draw causal relationships. In addition, our study only considered one aspect of aesthetic outcome (ie, symmetry). The study sample consisted of patients in various stages of reconstruction, including those who had yet to undergo reconstruction and those who were in the process of reconstruction. We did not limit the study to patients who had completed reconstruction, making it difficult to compare it with other studies where body image outcomes are evaluated only at the completion of reconstruction. This is because we found value in evaluating the relationship between symmetry and body image as patients undergo the lengthy process of breast reconstruction, which can take months or years to complete.
In summary, our findings suggest that it is important to consider objectively measured aesthetic reconstruction outcomes in conjunction with patient values in a clinical setting. Measurement of asymmetry in itself may not change patient outcomes; however, we have demonstrated that asymmetry is associated with body image outcomes. These findings must be considered within the context of both objective symmetry outcome and patient's subjective body image investment being relevant to patient's satisfaction with their surgical reconstruction. We believe our findings will spur future research to identify algorithms that are relatively easy to apply in the assessment of breast aesthetic appearance, which will help predict important patient outcomes. We also hope that our findings have clinical utility in aiding health care providers to deliver better-targeted treatment, may it be via reconstructive surgery procedures or through body image-focused interventions.
